Found: 16
Select item for more details and to access through your institution.
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.
- Published in:
- Journal of NeuroVirology, 2016, v. 22, n. 6, p. 852, doi. 10.1007/s13365-016-0448-1
- By:
- Publication type:
- Article
Predictors of Renal Outcome in HIV-Associated Nephropathy.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 8, p. 1282, doi. 10.1086/529385
- By:
- Publication type:
- Article
Ineffective central nervous system HIV suppression of once-a-day maraviroc and ritonavir-boosted darunavir dual therapy: four case reports.
- Published in:
- International Journal of STD & AIDS, 2016, v. 27, n. 4, p. 321, doi. 10.1177/0956462415584486
- By:
- Publication type:
- Article
Ineffective central nervous system HIV suppression of once-a-day maraviroc and ritonavir-boosted darunavir dual therapy: four case reports.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 4, p. 540, doi. 10.1093/infdis/jir380
- By:
- Publication type:
- Article
Virological Response to Initial Antiretroviral Regimens Containing Abacavir or Tenofovir.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 5, p. 710, doi. 10.1086/605024
- By:
- Publication type:
- Article
Reconstitution of Herpes Simplex Virus-Specific T Cell Immunity in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 3, p. 410, doi. 10.1086/510623
- By:
- Publication type:
- Article
Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 671, doi. 10.1093/jac/dkr493
- By:
- Publication type:
- Article
Factors influencing lopinavir and atazanavir plasma concentration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 1, p. 129, doi. 10.1093/jac/dkp408
- By:
- Publication type:
- Article
Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103498
- By:
- Publication type:
- Article
Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018164
- By:
- Publication type:
- Article
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 4, p. 353, doi. 10.1001/jama.2012.6936
- By:
- Publication type:
- Article
Development and application of a new measure of engagement in out-patient HIV care.
- Published in:
- HIV Medicine, 2017, v. 18, n. 4, p. 267, doi. 10.1111/hiv.12427
- By:
- Publication type:
- Article
Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 368, doi. 10.1111/hiv.12302
- By:
- Publication type:
- Article
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μ L in the UK.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μ L in the UK.
- Published in:
- HIV Medicine, 2012, v. 13, n. 1, p. 73, doi. 10.1111/j.1468-1293.2011.00956.x
- By:
- Publication type:
- Article